Topic: Health service policy

The new Government have made several announcements about science and the NHS, including a new Artificial Intelligence lab. But what does it mean for cancer?

With a new Prime Minister in office, the Government’s commitments to supporting the NHS and building on the strength of science in the UK must become reality.

Researchers have gathered the most complete picture of how long people wait for a cancer diagnosis in England. And there’s huge variation between referrals.

NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients.

All men with suspected prostate cancer should be offered a specialist MRI scan, before a biopsy. That’s the new recommendation, but is the NHS ready?

With NHS budgets stretched, it’s critical that cancer drugs offer value for money. We’ve teamed up with the Greater Manchester Health and Social Care Partnership to investigate a different approach to drug pricing.

The NHS long-term plan contains ambitious commitments to diagnose more cancers earlier and boost prevention, but it lacks detail on tackling staff shortages.

We pick out 6 of the stories that defined cancer policy and politics in 2018, including Brexit and the Prime Minister’s commitment to early diagnosis.

Our new report estimates the number of cancer staff the NHS will need in the future so that people with cancer receive the best possible care.

With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments.